Evaluating long-term outcomes in COVID-19 pneumonia survivors
Multiparametric Evaluation of One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia After Intensive Care Unit
This study looks at the long-term health and well-being of people who were in intensive care for severe COVID-19 pneumonia to see how they recover over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Nice Academic / other |
| Locations | 1 site (Nice) |
| Trial ID | NCT04401111 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the long-term physical and psychological effects on patients who were hospitalized in intensive care for severe COVID-19 pneumonia. It will evaluate respiratory sequelae and quality of life at multiple time points: 3 months, 6 months, 1 year, and 5 years post-ICU stay. The study will be conducted at the consultation department of the Nice CHU, focusing on patients who experienced acute respiratory distress syndrome (ARDS) due to SARS-CoV-2. By gathering this data, the study seeks to provide insights into the recovery process and ongoing challenges faced by these patients.
Who should consider this trial
Good fit: Ideal candidates include patients who were hospitalized in the ICU for ARDS related to COVID-19 and have tested positive for SARS-CoV-2.
Not a fit: Patients who were not hospitalized in the ICU for COVID-19 or those with negative SARS-CoV-2 tests will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of the long-term impacts of severe COVID-19, leading to better care strategies for survivors.
How similar studies have performed: While there is limited data on long-term outcomes specifically for COVID-19 pneumonia survivors, similar studies on ARDS patients have shown the importance of understanding post-ICU sequelae.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients hospitalized in ICU for an ARDS table * PCR SARSCoV-2 nasopharyngeal or positive pulmonary samples
Where this trial is running
Nice
- CHU de Nice — Nice, France (Recruiting)
Study contacts
- Study coordinator: Clément SACCHERI
- Email: saccheri.c@chu-nice.fr
- Phone: 0033492035510
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.